MedyMatch Technology and Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics, announced their strategic alliance on Wednesday to integrate technologies, allowing medical staff to detect a stroke in emergency care settings, quickly and accurately.
Doctors can effectively treat ischemic stroke, which occurs when blood vessels clot and obstruct blood flow to the brain if they administer a particular drug within three hours of symptom onset. However, they find too much critical time passes in the diagnosis process.
“Emergency treatment is needed to recognize and treat brain bleeds as quickly as possible and is critical in ensuring minimal damage,” said Peter Rasmussen, medical director of Cleveland Clinic’s Distance Health Program.
|CereTom CT scanner|
The alliance will integrate ambulances and other emergency vehicles that carry Samsung NeuroLogica CereTom CT scanner with MedyMatch’s A.I. technologies to allow the medical team to quickly determine whether a patient is having a stroke caused by a blood clot or a hemorrhage.
Caregivers can use Samsung NeuroLogica’s CereTom, the portable 8-slice CT scanner, in mobile stroke units (MSU) integrated with MedyMatch A.I. technology that allows medical caregivers to rapidly perform high-quality non-contrast, angiography, and contrast perfusion scans on the go.
“Our collaboration with MedyMatch is one more step forward in advanced technology to support better treatment of stroke,” said Phillip Sullivan, president and chief executive officer at Samsung NeuroLogica.
MedyMatch uses artificial intelligence and advanced cognitive analytics to develop real-time decision support tools and applications.
“We are on the threshold of the next evolutionary step in imaging,” said Gene Saragnese, chairman & CEO of MedyMatch, “Imaging technological development has been historically focused on providing clinicians the best possible image, resolution, coverage, and dose; however, MedyMatch’s artificial intelligence applications will leap this paradigm forward, enabling Imagers to provide clinical answers and not just images, thereby creating truly intelligent imaging machines that assist physicians every day.”
<© Korea Biomedical Review, All rights reserved.>